Despite the introduction of a new product, shares of Lucira Health Inc. (Nasdaq: LHDX) were down -33.03% at $0.4018 at the time of our last check in pre-market trading.
What kind of product has LHDX released?
The Canadian launch of Lucira Connect, a new virtual care program, was recently announced by Lucira Health (LHDX), which offers its test users the opportunity to test, know and understand about treatment options, access a telehealth consultation, and, if necessary, receive a prescription from home, all for the cost of the test alone, excluding prescription costs.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
With intentions to expand, Lucira Health presently provides the Lucira Test in British Columbia, Ontario, and Alberta. The self-administration of LHDX’s straightforward at-home molecular COVID-19 & Flu test is the first step of the user-friendly web-based platform called Lucira Connect, which may be found at www.luciraconnect.com.
Users may capture their test findings with their smartphone and receive PCR-quality, 99% accurate results in less than 30 minutes. Individuals will have the opportunity to obtain a free virtual telemedicine consultation with an impartial medical expert to evaluate their potential risks and recommended treatment choices if the test results for COVID-19 or the flu are positive.
To manage the health of any family and stop the spread of COVID-19 and the flu, quick diagnosis and treatment are necessary. LHDX has been on a mission to transform the testing sector ever since it was founded by providing precise and comprehensive healthcare from the convenience and security of every home.
One of the quickest and easiest methods to determine whether someone has COVID-19 or the flu, comprehend what to do about it, and receive proper therapy, if recommended by a medical expert, is through the Lucira Connect service. Through these collaborations, LHDX hopes to enhance outcomes by making it easier for individuals to navigate COVID-19 and flu and get trustworthy information about their health.
What further plans does LHDX have for the recently started test?
In order to link people who test positive for COVID-19 and the flu on the Lucira test with an outpatient team to talk about suitable treatment options, Lucira has partnered with Medi-Call. With amazing technology from Lucira Health (LHDX), customers may check their COVID-19 or flu level at home and receive PCR-quality findings. Due to Medi-Call’s representation on the Lucira Connect platform, LHDX will assist in increasing its visibility to more potential clients and customers.
